IP Library Granted Patent US 9,050,094
Granted Patent B2
US 9,050,094 · App. 12/407,709 · Granted Jun 9, 2015

Methods and devices for passive residual lung volume reduction and functional lung volume expansion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,050,094
App. No.
12/407,709
Granted
Jun 9, 2015
Kind
B2
Abstract

The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.

Claims (22)

1. A catheter for isolating and deflating a hyperinflated lung compartment, said catheter comprising:

a catheter body having a distal end, a proximal end, and at least one lumen extending from the distal end to the proximal end, wherein at least a distal portion of the catheter body is adapted to be advanced through the airways of the lung;

a transparent expandable occluding member disposed near a distal end of the catheter body, wherein said occluding member is adapted to be expanded in an airway which feeds the hyperinflated lung compartment such that access to the compartment is provided only through the lumen when the occluding member is expanded, and wherein the shape and material of the transparent occluding member are configured such that the transparent occluding member forms a wide angle lens, wherein the wide angle lens is formed by attaching a proximal end of the transparent occluding member circumferentially to an outer surface of the catheter body and attaching a distal portion of the transparent occluding member circumferentially to an inner surface of the lumen; and

a one-way flow element adapted to be disposed within or in-line with the lumen so that flow in a distal-to-proximal direction is allowed and flow in a proximal-to-distal direction is inhibited or prevented.

2. A catheter as in claim 1 , wherein the occluding member is expandable to sealingly engage the walls of the airway.

3. A catheter as in claim 1 , wherein the occluding member is an elastomeric balloon.

4. A catheter as in claim 1 , wherein the catheter body has a length in the range from 20 cm to 200 cm and a diameter near the distal end in the range from 0.1 mm to 10 mm.

5. A catheter as in claim 1 , wherein the expandable occluding member is an inflatable balloon, cuff, or braided balloon.

6. A catheter as in claim 1 , wherein the expandable occluding member has a width in the range from 1 mm to 30 mm when fully expanded.

7. A catheter as in claim 1 , wherein the one-way flow element is disposed in the lumen.

8. A catheter as in claim 7 , wherein the one-way flow element is disposed in the lumen near the distal end of the catheter body.

9. A catheter as in claim 1 , further comprising a hub disposed on the proximal end of the catheter body.

10. A catheter as in claim 9 , wherein the one-way flow element is disposed in the hub.

11. A catheter as in claim 10 , wherein the hub is removable and can be attached in-line with the lumen.

12. A catheter as in claim 1 , wherein the expandable member is configured to focus or diffuse a therapeutic electromagnetic energy delivered to the airway or the lung compartment.

13. A catheter for isolating and deflating a hyperinflated lung compartment, said catheter comprising:

a catheter body having a distal end, a proximal end, and at least one lumen extending from the distal end to the proximal end, wherein at least a distal portion of the catheter body is adapted to be advanced through the airways of the lung; and

a transparent expandable occluding member disposed near a distal end of the catheter body, wherein said occluding member is adapted to be expanded in an airway which feeds the hyperinflated lung compartment such that access to the compartment is provided only through the lumen when the occluding member is expanded, and wherein the shape and material of the transparent occluding member are configured such that the transparent occluding member forms a wide angle lens, wherein the wide angle lens is formed by attaching a proximal end of the transparent occluding member circumferentially to an outer surface of the catheter body and attaching a distal portion of the transparent occluding member circumferentially to an inner surface of the lumen;

wherein the catheter is configured to connect to a console comprising a one-way flow control assembly in-line with the lumen so that flow in a distal-to-proximal direction is allowed and flow in a proximal-to-distal direction is inhibited or prevented.

14. A catheter as in claim 13 , wherein the occluding member is expandable to sealingly engage the walls of the airway.

15. A catheter as in claim 13 , wherein the occluding member is an elastomeric balloon.

16. A catheter as in claim 13 , wherein the expandable member is configured to focus or diffuse a therapeutic electromagnetic energy delivered to the airway or the lung compartment.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2010
From: ALJURI, NIKOLAI; PERKINS, RODNEY C.; OLIVERA, RYAN; NGUYEN, HOANG; RADHAKRISHNAN, SRI; BEYHAN, NIYAZI
To: PULMONX
Reel/Frame 023894/0550 →